Home Print this page Email this page Small font size Default font size Increase font size
Users Online: 238
Home About us Editorial board Search Ahead of print Current issue Archives Submit article Instructions Subscribe Contacts Login

Ahead of Print policy

Articles published online under the Ahead of Print model are considered published and can be cited and quoted using the DOI as the reference source. Wolters Kluwer Medknow has a policy that changes will not be made after publication of an article without following accepted procedures for making corrections to the scientific record.

 Coming soon

1.  Tumor necrosis factor-alpha antibodies in fistulizing Crohnæs disease: An updated systematic review and meta-analysis
1.  Efficacy of intense pulsed light (IPL) therapy with topical benzoyl peroxide 5% versus benzoyl peroxide 5%-alone in mild-to-moderate acne vulgaris: a randomized controlled trial
2.  Impact of CYP2C19 polymorphisms on serum concentration of voriconazole in Iranian hematological patients
3.  Comparing the Efficacy of Low Dose and Conventional Dose of Oral Isotretinoin in Treatment of Moderate and Severe Acne Vulgaris
4.  Missing the benefit of metformin in acute myeloid leukemia: a problem of contrast?
5.  How do Iranian pharmacists, body builders and their coaches think, believe and behave about sport supplements
6.  Causes of medication errors in intensive care units from perspective of healthcare professionals
7.  Ciprofloxacin use in hospitalized children: approved or off-label?
8.  Prescription pattern analysis of nonsteroidal anti-inflammatory drugs in the Northeastern Iranian population
1.  An inter-professional collaboration between medicine and pharmacy schools: Designing and evaluating a teaching program on practical prescribing
2.  Melatonin supplementation may improve the outcome of patients with hemorrhagic stroke in the intensive care unit
1.  Osteonecrosis of the jaws in patient received bisphosphonates and Sunitinib separately: a case report
2.  Intracranial hemorrhage in methanol toxicity: challenging the probable heparin effect during hemodialysis, a case report
1.  Intralesional Bevacizumab (Avastin®) as a novel addition to infantile hemangioma management: a medical hypothesis